Fund shareholders of Celldex Therapeutics Inc
ISIN US15117B2025 · United States · LEI 529900F018DMYWH38923
- Fund shareholders
- 247
- Of which ETFs
- 49 198 other funds
- Value held
- ≈ 1.1B $ 1.1B $ · 7.8M SEK
- Share of capital
- 39.5 % of 78.5M shares on Jul 29, 2026
247 funds hold this company. This table lists the 246 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. The “Fund reports” tab lists it, with its weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 1,632 | 60.7K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,623 | 60.4K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Small Cap Stock K6 Fund Fidelity Concord Street Trust | 1,519 | 57.8K $ | 0.28 % | 0.00 % | as of Jul 31, 2026 ↗ |
| American Century Small Cap Growth Insights ETF American Century ETF Trust | 1,397 | 43.9K $ | 0.26 % | 0.00 % | as of May 31, 2026 ↗ |
| Victory Science & Technology Fund Victory Portfolios III | 1,379 | 52.5K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| SA T. Rowe Price Allocation Moderately Aggressive Portfolio SUNAMERICA SERIES TRUST | 1,349 | 51.3K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 1,296 | 48.2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Strategic Allocation: Aggressive Fund American Century Strategic Asset Allocations Inc | 1,263 | 48.1K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,034 | 38.5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,006 | 38.3K $ | 0.07 % | 0.00 % | as of Jul 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 971 | 37K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Pacer WealthShield ETF Pacer Funds Trust | 938 | 35.7K $ | 0.15 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 853 | 31.7K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 792 | 24.9K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Victory Cornerstone Aggressive Fund Victory Portfolios III | 778 | 24.5K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 777 | 28.9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Strategic Allocation: Moderate Fund American Century Strategic Asset Allocations Inc | 759 | 28.9K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 750 | 27.9K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 694 | 25.8K $ | 0.96 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 636 | 20K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 500 | 15.7K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 453 | 16.9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 448 | 17.1K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 420 | 15.6K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 416 | 15.8K $ | 0.15 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 414 | 15.8K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 413 | 15.4K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 321 | 11.9K $ | 0.06 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Strategic Allocation: Conservative Fund American Century Strategic Asset Allocations Inc | 314 | 12K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 271 | 10.1K $ | 0.06 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Sustainable U.S. Market Fund Fidelity Summer Street Trust | 270 | 10.3K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 262 | 9.7K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Small Cap Value ETF Fidelity Covington Trust | 256 | 9.5K $ | 0.14 % | 0.00 % | as of Jun 30, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 253 | 9.6K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 210 | 7.8K $ | 0.07 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 199 | 7.6K $ | 0.04 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 194 | 7.2K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Kennedy Capital Small Cap Growth Fund INVESTMENT MANAGERS SERIES TRUST II | 125 | 4.7K $ | 0.66 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 116 | 4.3K $ | 0.06 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 89 | 3.3K $ | 0.09 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Small Cap Growth ETF Fidelity Covington Trust | 73 | 2.7K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 71 | 2.2K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 66 | 2.5K $ | 0.03 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 50 | 1.6K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 23 | 722.9 $ | 0.06 % | 0.00 % | as of May 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 22 | 818.6 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 1.17 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 2.56 % | as of Jun 30, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 2.16 % | as of Jun 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.33 % | as of May 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 1.17 % | as of Sep 30, 2025 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 1.02 % | as of Jun 30, 2026 ↗ |
| DWS Small Cap Growth Fund DEUTSCHE DWS INVESTMENT TRUST | 1.00 % | as of Jun 30, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 0.96 % | as of Jun 30, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 0.89 % | as of Jul 31, 2026 ↗ |
| DWS Small Mid Cap Growth VIP DEUTSCHE DWS VARIABLE SERIES II | 0.86 % | as of Jun 30, 2026 ↗ |
| THE HARTFORD SMALL COMPANY FUND HARTFORD MUTUAL FUNDS, INC | 0.84 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 245 | +20 | 30,956,977 | +21.7 % |
| 2026Q2 | 225 | +12 | 25,437,695 | -1.1 % |
| 2026Q1 | 213 | +1 | 25,733,608 | +2.1 % |
| 2025Q4 | 212 | +4 | 25,212,666 | +6.5 % |
| 2025Q3 | 208 | -2 | 23,671,171 | -17.4 % |
| 2025Q2 | 210 | +7 | 28,664,073 | -6.2 % |
| 2025Q1 | 203 | -19 | 30,569,939 | +1.6 % |
| 2024Q4 | 222 | +6 | 30,099,235 | +1.0 % |
| 2024Q3 | 216 | -12 | 29,799,647 | -1.0 % |
| 2024Q2 | 228 | +35 | 30,103,382 | +49.0 % |
| 2024Q1 | 193 | +1 | 20,205,896 | -1.6 % |
| 2023Q4 | 192 | 20,536,949 |
Institutional managers
218 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 8,560,476 | 271.5M $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 5,840,567 | 185.3M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,369,885 | 170.3M $ | as of Mar 31, 2026 |
| FMR LLC | 3,749,048 | 118.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 3,229,939 | 102.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,804,168 | 88.9M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 2,696,616 | 85.5M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,086,332 | 66.2K $ | as of Mar 31, 2026 |
| Eversept Partners, LP | 1,788,016 | 56.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,688,074 | 53.6M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 1,356,082 | 43M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 1,283,979 | 40.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,253,532 | 39.8M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,224,165 | 38.8M $ | as of Mar 31, 2026 |
| NOVO HOLDINGS A/S | 1,200,000 | 38.1M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 1,200,000 | 38.1M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,059,534 | 33.6M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1,037,000 | 32.9M $ | as of Mar 31, 2026 |
| Fisher Asset Management, LLC | 1,013,648 | 32.2M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 988,416 | 31.4M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 923,696 | 29.3M $ | as of Mar 31, 2026 |
| Elmind Capital, LP | 865,000 | 27.4M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 856,310 | 27.2M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 708,647 | 22.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 665,370 | 21.1M $ | as of Mar 31, 2026 |
Declared shareholders of Celldex Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Kynam Capital Management, LP and 2 others | 6.78 % | 0 | as of Jun 30, 2026 · SCHEDULE 13G |
| T. Rowe Price Associates, Inc. | 6.00 % | 4,686,187 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Celldex Therapeutics Inc". https://titelia.com/en/stocks/celldex-therapeutics-inc-US15117B2025